Encorafenib plus binimetinib in patients (pts) with previously untreated BRAF V600E-mutant advanced non-small cell lung cancer (NSCLC): An open-label, multicenter phase II trial (IFCT-1904 ENCO-BRAF)
Auteurs / Authors: D. Planchard, J. Mazieres, C. Mascaux, F. Guisier, P. Tomasini, M. Wislez, D. Moro-Sibilot, S. Cousin, A.B. Cortot, S. Couraud, V. Fallet, C. Guguen, A. Lagrange, A-C. Madroszyk Flandin, J. Otto, M. Pérol, B. Roch, E. Amour, F. Morin, C. Ricordel
Journal / Conference: ESMO
Année / Year: 2024
PMID: Mini oral session
Lien vers la publication: https://www.annalsofoncology.org/article/S0923-7534(24)02835-7/fulltext
